|Grand Designs featured Accsys on Wednesday evening. Still holding and hopeful 😃|
|Hope it comes to nothing. We're Forest Green Rovers and we want to stay in Forest Green.|
|Come on AXS get quoting for this:
|According to a friend of mine Accoya continues to fly off the shelf in the UK. However, thereby lies one issue, and that is that the UK is by far the biggest market for the product (I believe it accounts for around 25% of worldwide sales)with relatively slow sales growth in all the other markets where it's sold. I understand that there is a good push going on in the USA market and it would only need that to succeed to see a big jump in the share price That said, though, you wouldn't want it immediately, as the production needs to be ramped up first. It'll be interesting to see how things develop over the next year, or so. I've been a shareholder for some years now and look at it as a medium-long term investment, topping up from time to time on dips. As for Tricoya, I don't have much feedback, but it certainly has the potential for good growth too, from the little of what I've heard.|
|Thanks for your summary Stephen. Most useful to know the practicalities and cost implications. I am still not sure what is happening to the Freiburg plant but when Hull comes on stream this share will probably be rerated by a significant margin. It appears that Accoya and Tricoya are increasingly visible to the trade and feedback from Architects is that it is the material of choice for shop windows and future proof windows!
Time will tell.|
|Very difficult to compare as trycoa comes in sheet form but what it is replacing comes in all shapes and sizes. I would say traditional timber costs between 60% to 80% less. Traditional timber does not last anything like as long as trycoa but most builders are not bothered, they only think of cost. I only use it if it is asked for.|
What does an 8*4 competitive product cost ?|
|Well i am a joiner and have used both accoya and tricoya and can report that both are excellent products and indeed tricoya will be a revalation. I have been thinking about investing in this company for longer than i care to remember but never have. Two things prevent me - cost - the tricoya i have used is a waterproof mdf costing around £100 per 8' * 4' sheet, i will not invest until this price is significantly lower. No2 can another company copy this? I suspect that they can and until i am happy that they cant i will not invest|
|Feedback from our local joiner is the same. He has made several sets of windows out of Accoya and reports that it is excellent to work with. Can anyone guide me as to how the factory in Frieburg is progressing? I am slowly accumulating shares as I believe this company could be heading toward significant growth.|
What you might consider doing now is to get in touch with other users to get a wider range of opinion. If the consensus is that Tricoya is likely to be huge , then that could be a very good indicator, but one firm could simply be wrong . ---: interesting|
|I spoke with a local joinery company about a week ago who are well acquainted with Accoya and Tricoya. Whilst they were very positive about Accoya they described Tricoya as revolutionary and expected it to be huge.|
|Interesting uptick on the share price over the past few days. Mind you, it's only really recovering from the recent drops. There doesn't appear to be anything on the wires, and it could well just be another blip in a pretty volatile SP, but maybe they are finally hitting that elusive cash-flow break even position? The UK market for Accoya remains very strong from what I hear, but I have no idea about growth in other markets.|
|Accsys Technologies Signs Up BP Ventures To Tricoya Consortium
|Proactive Investors interview with Paul Clegg on the 14th December.
I agree that we need to know more before making an informed decision . I will try to find out more.|
|That's not good news.|
|IMHO, it's pretty difficult to take any firm position, positive or negative, on this latest news, without a great deal more information, which I doubt we'll get. The one ongoing positive is that, in the UK at least, Accoya is still selling very well indeed. The higher production is currently certainly required, but, as you rightly imply, at what cost?|
|So, the interim results for the 6 months ended 30th September are due next Monday, 30th November. It'll be interesting to see if the company will have now reached a cash-flow break even position. This was clearly the hope for the board to happen at some point this year.|
|26 November 2015
NYSE Euronext Amsterdam: AXS
26 November 2015
ACCSYS TECHNOLOGIES PLC
("Accsys" or "the Company")
Solvay and Accsys enhance their collaboration to accelerate marketing, sales and manufacturing of Accoya(R)
Accsys, the chemical technology group, focused on the acetylation of wood, today is pleased to announce details of a new agreement with Solvay Acetow Gmbh ("Solvay"), to refine the relationship between the two parties for the licensing, marketing and manufacturing of Accoya(R) . This new agreement provides the framework and funding for a significant increase in the manufacturing capacity in Arnhem.
Solvay will purchase a minimum 76,000 cubic metres of Accoya from the Arnhem plant over the period from 2016 to 2020 (the "offtake commitment") and as a result of the increased manufacturing capacity in Arnhem and consequent greater sales capacity, under the new agreement Solvay will review the optimal timing to construct its 63,000 cubic metres Accoya manufacturing plant.
The enhanced relationship with Solvay will benefit both parties, with the increased manufacturing capacity and resulting sales expected to be achieved for Accoya in a faster timescale than would otherwise have been possible.
Accsys will double the existing manufacturing capacity at its Arnhem site in stages, up to 80,000 cubic metres per annum from 40,000 cubic metres. The initial incremental 20,000 cubic metres capacity is expected to come on stream in mid-2017.
The licence agreement covering Europe has been amended to provide increased royalties to Accsys and the return to Accsys of the selling rights for 20 European countries.
Accsys will provide sales and marketing services to Solvay on agreed terms in respect of Solvay's exclusive European territories.
A combination of loans and fees from Solvay, in addition to those due under the offtake commitment, will fund the majority of the initial increase in manufacturing capacity at Arnhem, with the balance to be met by Accsys' own resources, including the possible sale and leaseback of land at Arnhem.
Paul Clegg, CEO of Accsys said: "We are pleased to be able to cement our relationship with Solvay through this agreement to expand our Accoya(R) manufacturing capacity and Solvay's commitment to purchase significant volumes from Accsys over the coming years. This is an exciting step in the development of our business and is further evidence of the fruits of our strategy to maximise returns from our technology platform and resultant product offerings."
These agreements allow the market development of Accoya to continue and optimises the roll out of manufacturing capacity under its partnering program with Solvay, increasing the certainty of supply for Accoya customers and users. It also enables Accsys to continue to develop global markets effectively, building on the expertise that it has developed over the last few years.
Accsys's interim results for the six months ended 30 September 2015 will be released on 30 November 2015.
|Most would agree with you, but what can be done, realistically. CEOs know this but are so selfish they don't care what anybody thinks, as long as they are impotent to change it.|
|Looked in here. I understand the science and can see it being a success. When I see Clegg paying himself £916k/yr for an as yet loss making company with a M.Cap of £57m that's way out of place.|
|The only thing that I can see that could remotely be connected to this drop was the announcement yesterday of an Extraordinary General Shareholders’ Meeting by Solvay, which is scheduled to take place on October 23rd. It's purpose, as far as I can see, is for the directors to propose to shareholders to grant it the authorization to increase the share capital of the company with a view to financing or refinancing the acquisition of Cytec in the U.S.
Of course I could be completely picking at straws here. :-)|
|Thanks TW- hope you're right. Promising reversion of most of yesterday's loss ... At least thus far today|
|I see absolutely no reason why the share price should have dropped so much today. It's similar to the weird, unexplained drop we saw just after the release of the preliminary results 2014/15, from where it's since recovered.
All I know from people in the UK distribution business is that Accoya is still flying off the shelf and gaining more market share.
"Some folk know more than we do?" Maybe! However, I really don't see it as a factor, and, as you rightly say, the share price is prone to big swings. IMHO they should still be heading for a cash-flow break even position this year, which should boost the share price further.
However, should there be a major upset due, then all bets are of course off.|